These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15096135)

  • 21. Comparative evaluation of the efficacy of four topical medications individually or in combination to treat grade I acne vulgaris.
    Biswas S; Mondal KK; Dutta RN; Sarkar DK
    J Indian Med Assoc; 2009 Apr; 107(4):219-22. PubMed ID: 19810365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recurrence in patients diagnosed with acne treated by isotretinoin and other methods].
    Bergler-Czop B; Brzezińska-Wcisło L
    Wiad Lek; 2006; 59(3-4):152-7. PubMed ID: 16813256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subantimicrobial-dose doxycycline in the treatment of moderate facial acne.
    Toossi P; Farshchian M; Malekzad F; Mohtasham N; Kimyai-Asadi A
    J Drugs Dermatol; 2008 Dec; 7(12):1149-52. PubMed ID: 19137768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and bacteriological evaluation of nadifloxacin 1% cream in patients with acne vulgaris: a double-blind, phase III comparison study versus erythromycin 2% cream.
    Plewig G; Holland KT; Nenoff P
    Eur J Dermatol; 2006; 16(1):48-55. PubMed ID: 16436342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 1450-nm diode laser for facial inflammatory acne vulgaris: dose-response and 12-month follow-up study.
    Jih MH; Friedman PM; Goldberg LH; Robles M; Glaich AS; Kimyai-Asadi A
    J Am Acad Dermatol; 2006 Jul; 55(1):80-7. PubMed ID: 16781297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomal methylene blue hydrogel for selective photodynamic therapy of acne vulgaris.
    Fadel M; Salah M; Samy N; Mona S
    J Drugs Dermatol; 2009 Nov; 8(11):983-90. PubMed ID: 19894365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase 4 study to assess tretinoin pump for the treatment of facial acne.
    Eichenfield LF; Nighland M; Rossi AB; Cook-Bolden F; Grimes P; Fried R; Levy S;
    J Drugs Dermatol; 2008 Dec; 7(12):1129-36. PubMed ID: 19137766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized double-blind study to assess the effects of silicic acid compared to placebo in patients with mild to moderate acne.
    Fernandez C; Adamson K; Dale M; Cunliffe WJ
    J Dermatolog Treat; 2005; 16(5-6):287-94. PubMed ID: 16428147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects and side-effects of spironolactone therapy in women with acne.
    Yemisci A; Gorgulu A; Piskin S
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):163-6. PubMed ID: 15752283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful acne management in Apert syndrome twins.
    Benjamin LT; Trowers AB; Schachner LA
    Pediatr Dermatol; 2005; 22(6):561-5. PubMed ID: 16354263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents.
    Kaymak Y; Taner E; Taner Y
    Int J Dermatol; 2009 Jan; 48(1):41-6. PubMed ID: 19126049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of topical cyproterone acetate alcohol lotion versus placebo in the treatment of the mild to moderate acne vulgaris: a double blind study.
    Iraji F; Momeni A; Naji SM; Siadat AH
    Dermatol Online J; 2006 Mar; 12(3):26. PubMed ID: 16638440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of acne vulgaris with 2% topical tea lotion.
    Sharquie KE; Al-Turfi IA; Al-Shimary WM
    Saudi Med J; 2006 Jan; 27(1):83-5. PubMed ID: 16432600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azithromycin pulses in the treatment of inflammatory and pustular acne: efficacy, tolerability and safety.
    Antonio JR; Pegas JR; Cestari TF; Do Nascimento LV
    J Dermatolog Treat; 2008; 19(4):210-5. PubMed ID: 18608737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of inflammatory facial acne vulgaris with intense pulsed light and short contact of topical 5-aminolevulinic acid: a pilot study.
    Rojanamatin J; Choawawanich P
    Dermatol Surg; 2006 Aug; 32(8):991-6; discussion 996-7. PubMed ID: 16918560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life in mild to moderate acne: relationship to clinical severity and factors influencing change with treatment.
    Jones-Caballero M; Chren MM; Soler B; Pedrosa E; Peñas PF
    J Eur Acad Dermatol Venereol; 2007 Feb; 21(2):219-26. PubMed ID: 17243958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of ALA-PDT vs blue light in the treatment of acne.
    Akaraphanth R; Kanjanawanitchkul W; Gritiyarangsan P
    Photodermatol Photoimmunol Photomed; 2007 Oct; 23(5):186-90. PubMed ID: 17803597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Light-emitting diode 415 nm in the treatment of inflammatory acne: an open-label, multicentric, pilot investigation.
    Tremblay JF; Sire DJ; Lowe NJ; Moy RL
    J Cosmet Laser Ther; 2006 Apr; 8(1):31-3. PubMed ID: 16581683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients.
    Shaw JC
    J Am Acad Dermatol; 2000 Sep; 43(3):498-502. PubMed ID: 10954662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.